Embryonic Ploidy Status in the Oncofertility Population

NCT03350230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-05-03

No results posted yet for this study

Summary

looking at aneuploidy rates in embryos from patients who are going to or have undergone treatment for a malignancy with gonadotoxic treatment.

Conditions

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Jason Franasiak, MD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-03-27
Completion
2022-07-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350230 on ClinicalTrials.gov